Recently, Almeida et al.[12] emphasized the clinical heterogeneity of skeletal dysplasias (achondroplasia and hypochondroplasia) associated with FGFR3 mutations, and the importance of undertaking mutation analysis to confirm the clinical diagnosis and to establish an appropriate prognosis and genetic counseling[12]. This evidence concerns the gene FGFR3 and skeletal dysplasia.